Business Description
ISIN : US9467841055
Total Employee Number:
340Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | 3.43 | |||||
Interest Coverage | 3.42 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.83 | |||||
Beneish M-Score | -2.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 22.1 | |||||
3-Year FCF Growth Rate | 44.2 | |||||
3-Year Book Growth Rate | 17 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 14.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.84 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.22 | |||||
9-Day RSI | 63.46 | |||||
14-Day RSI | 60.62 | |||||
3-1 Month Momentum % | 35.23 | |||||
6-1 Month Momentum % | -0.28 | |||||
12-1 Month Momentum % | -36.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.85 | |||||
Quick Ratio | 1.85 | |||||
Cash Ratio | 0.81 | |||||
Days Sales Outstanding | 49.93 | |||||
Days Payable | 51.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -3.88 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.11 | |||||
Operating Margin % | 22.87 | |||||
Net Margin % | 11.18 | |||||
EBITDA Margin % | 35.86 | |||||
FCF Margin % | 20.42 | |||||
OCF Margin % | 24.3 | |||||
ROE % | 3.7 | |||||
ROA % | 2.5 | |||||
ROIC % | 3.78 | |||||
3-Year ROIIC % | 9.06 | |||||
ROC (Joel Greenblatt) % | 271.85 | |||||
ROCE % | 5.32 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 37.76 | |||||
Forward PE Ratio | 14.1 | |||||
PE Ratio without NRI | 32.53 | |||||
PS Ratio | 4.18 | |||||
PB Ratio | 1.28 | |||||
Price-to-Free-Cash-Flow | 20.53 | |||||
Price-to-Operating-Cash-Flow | 17.21 | |||||
EV-to-EBIT | 22.88 | |||||
EV-to-EBITDA | 14.64 | |||||
EV-to-Forward-EBITDA | 12.3 | |||||
EV-to-Revenue | 5.28 | |||||
EV-to-Forward-Revenue | 4.51 | |||||
EV-to-FCF | 25.87 | |||||
Earnings Yield (Greenblatt) % | 4.37 | |||||
FCF Yield % | 4.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:WAY
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Waystar Holding Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,205.737 | ||
| EPS (TTM) ($) | 0.702 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 37.16 | ||
| 14-Day RSI | 60.62 | ||
| 14-Day ATR ($) | 1.137227 | ||
| 20-Day SMA ($) | 25.159 | ||
| 12-1 Month Momentum % | -36.05 | ||
| 52-Week Range ($) | 17.26 - 40.35 | ||
| Shares Outstanding (Mil) | 191.75 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Waystar Holding Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Waystar Holding Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-17 08:30 | In 153 days | ||
| Annual report for 2026 | 2027-02-17 | In 152 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-17 | In 152 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-29 16:30 | In 42 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 41 days | ||
| Investor Day | 2026-08-25 13:00 | 25.35 (-0.55%) | ||
| Second quarter earnings conference call for 2026 | 2026-07-29 16:30 | 23.69 (-0.59%) | ||
| Second quarter earnings results for 2026 | 2026-07-29 | 23.69 (-0.59%) | ||
| 46th Annual William Blair Growth Stock Conference | 2026-06-02 10:40 | 21.92 (+8.14%) | ||
| General meeting for 2026 | 2026-06-01 10:00 | 19.90 (+2.63%) |
Waystar Holding Corp Frequently Asked Questions
Guru Commentaries on NAS:WAY
Waystar is a leading cloud-based revenue cycle management platform that supports over 30,000 health care organizations, including 16 of the top 20 US hospitals. However, slower-than-expected demand for certain volume-based solutions reduced our confidence in the company’s profit cycle. We identified more compelling software investment opportunities that had moved back into our preferred market capitalization range, leading us to end our investment in Waystar.
Waystar, viewed as a software stock, was a detractor in the quarter due to stock-specific issues. The company provides mission-critical software for the hospitality industry, but its performance has been impacted by competitive worries and manufacturing challenges. This has led us to exit our position as we believe our original investment thesis is no longer valid.
Waystar has recently seen strong business momentum due to a struggling competitor which we believe will lead to accelerating revenue growth in the future. This positive outlook is supported by the company's ability to capitalize on market opportunities, positioning it well for growth despite industry challenges. We are optimistic about its potential to improve market share and drive profitable growth in the coming years.
Waystar is a health care information service company that connects payors and providers, primarily by processing bills and insurance claims for hospitals and doctors. The business is historically largely insulated from reimbursement changes or Washington policy noise. This resilience positions Waystar favorably in the current environment, making it an attractive addition to our portfolio as we focus on premier growth compounders.